Vir Biotechnology, Inc. (VIR) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$9.36
Day's range
$10.05

Vir Biotechnology Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 16.33 M $98.47 M   2.27% 11.75%
SB INVESTMENT ADVISERS (UK) LTD 02/18/2026 13.12 M $79.10 M   -21.38% 9.44%
ARCH VENTURE MANAGEMENT, LLC 02/17/2026 12.92 M $77.89 M   0.00% 9.30%
VANGUARD GROUP INC 01/29/2026 12.55 M $75.67 M   -1.96% 9.03%
GSK PLC 02/12/2026 8.55 M $51.56 M   100.00% 6.15%
STATE STREET CORP 02/13/2026 6.23 M $37.56 M   18.86% 4.48%
FMR LLC 02/17/2026 3.16 M $19.05 M   -13.16% 2.27%
MORGAN STANLEY 02/13/2026 2.68 M $16.16 M   -0.37% 1.93%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 2.54 M $15.29 M   -14.86% 1.83%
ORBIMED ADVISORS LLC 02/17/2026 2.38 M $14.36 M   0.00% 1.71%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 2.33 M $14.04 M   3.65% 1.68%
GOLDMAN SACHS GROUP INC 03/25/2026 1.57 M $9.46 M   3.10% 1.13%
ABRDN PLC 01/16/2026 1.39 M $8.39 M   -8.89% 1.00%
BALYASNY ASSET MANAGEMENT L.P. 02/17/2026 1.37 M $8.25 M   100.00% 0.99%
HUDSON BAY CAPITAL MANAGEMENT LP 02/13/2026 1.33 M $7.99 M   45.30% 0.95%
CANDRIAM S.C.A. 04/30/2026 1.03 M $6.22 M   100.00% 0.74%
MILLENNIUM MANAGEMENT LLC 02/17/2026 1.00 M $6.05 M   -28.21% 0.72%
BANK OF AMERICA CORP /DE/ 02/17/2026 930.91 K $5.61 M   132.16% 0.67%
02/17/2026 930.32 K $5.61 M   100.00% 0.67%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 904.48 K $5.45 M   -20.86% 0.65%
NORTHERN TRUST CORP 02/17/2026 848.47 K $5.12 M   -6.47% 0.61%
AMERIPRISE FINANCIAL INC 02/17/2026 731.31 K $4.41 M   276.44% 0.53%
BOXER CAPITAL MANAGEMENT, LLC 02/17/2026 625.00 K $3.77 M   100.00% 0.45%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 614.46 K $3.71 M   -47.35% 0.44%
NORDEA INVESTMENT MANAGEMENT AB 01/08/2026 609.73 K $3.55 M   -14.67% 0.44%
CLARIUS GROUP, LLC 01/14/2026 608.20 K $3.67 M   -1.79% 0.44%
SCHRODER INVESTMENT MANAGEMENT GROUP 02/13/2026 598.67 K $3.50 M   31.20% 0.43%
HRT FINANCIAL LP 02/12/2026 591.65 K $3.57 M   234.67% 0.43%
TWO SIGMA INVESTMENTS, LP 02/17/2026 589.56 K $3.56 M   -9.20% 0.42%
TWO SIGMA ADVISERS, LP 02/17/2026 577.70 K $3.48 M   14.62% 0.42%
IKARIAN CAPITAL, LLC 02/18/2026 575.71 K $3.47 M   -2.98% 0.41%
NUVEEN, LLC 02/12/2026 565.54 K $3.41 M   175.23% 0.41%
BANK OF NEW YORK MELLON CORP 02/10/2026 545.56 K $3.29 M   -2.06% 0.39%
BAKER BROS. ADVISORS LP 02/17/2026 542.54 K $3.27 M   0.00% 0.39%
ENSIGN PEAK ADVISORS, INC 02/12/2026 531.43 K $3.20 M   -4.24% 0.38%
ALTA PARTNERS MANAGEMENT COMPANY, L.P. 01/13/2026 509.92 K $3.07 M   0.00% 0.37%
CITADEL ADVISORS LLC 02/17/2026 489.23 K $2.95 M   -38.77% 0.35%
SIO CAPITAL MANAGEMENT, LLC 02/17/2026 478.34 K $2.88 M   0.00% 0.34%
PRINCIPAL FINANCIAL GROUP INC 02/02/2026 450.60 K $2.72 M   -1.12% 0.32%
JPMORGAN CHASE & CO 02/11/2026 418.60 K $2.52 M   -6.88% 0.30%
UBS GROUP AG 01/29/2026 417.97 K $2.52 M   94.62% 0.30%
INVESCO LTD. 02/19/2026 405.70 K $2.45 M   -2.93% 0.29%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 390.06 K $2.35 M   40.46% 0.28%
PANAGORA ASSET MANAGEMENT INC 02/13/2026 371.29 K $2.24 M   3.02% 0.27%
BARCLAYS PLC 02/13/2026 365.83 K $2.21 M   -10.86% 0.26%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 02/17/2026 327.39 K $1.97 M   -36.63% 0.24%
PUBLIC SECTOR PENSION INVESTMENT BOARD 02/13/2026 326.17 K $1.97 M   -11.19% 0.23%
CITIGROUP INC 02/13/2026 311.29 K $1.88 M   -3.78% 0.22%
AMERICAN CENTURY COMPANIES INC 02/13/2026 295.39 K $1.78 M   -0.21% 0.21%
PRUDENTIAL FINANCIAL INC 02/13/2026 281.54 K $1.70 M   11.58% 0.20%

Vir Biotechnology Inc institutional Ownership - FAQ's

During the previous two years, 293 institutional investors and hedge funds held shares of Vir Biotechnology Inc. The most heavily invested institutionals were:

Pictet Asset Management Holding SA: 1.48 M

Candriam S.C.A.: 1.14 M

Nuveen, LLC: 1.02 M

UBS Group AG: 744,142

Bank of New York Mellon Corp: 584,047

PRINCIPAL FINANCIAL GROUP INC: 547,753

83.17% of Vir Biotechnology Inc stock is owned by institutional investors.

Institutional investors have bought a total of 136.11 M shares in the last 24 months. This purchase volume represents approximately $1.33 B in transactions.